Skip to main content

Moderna, Inc. ownership: holders and insider trading

  • MRNA · Nasdaq
  • Biotechnology
  • S&P 500
$223.37−3.45%Close 13 Nov 2026 · Market value $87.52B

As filed, its directors and officers own 10.8% of the shares (proxy statement, 9 Mar 2026); 777 institutional managers reported holding 78.9% at 30 Jun 2026. Over the last twelve months, insiders sold $81.65M of shares on the open market, $80.51M of it under 10b5-1 plans set in advance, and bought none.

From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.

Largest holders

HolderTypeSharesOf the companySourceAs of
FMR LLCHolder58.9M14.8%Schedule 13G30 Sep 2026
Fidelity (FMR)Institution51.9M12.84%*Form 13F30 Jun 2026
The Vanguard GroupHolder42.0M10.39%*Form 13F30 Jun 2026
Stéphane Bancel · Chief Executive Officer and DirectorInsider30.7M7.6%Proxy statement9 Mar 2026
BlackRock, Inc.Holder30.6M7.57%*Form 13F30 Jun 2026
Vanguard Capital ManagementHolder25.9M6.53%Schedule 13G31 Mar 2026
Capital GroupInstitution22.3M5.51%*Form 13F30 Jun 2026
Capital World InvestorsHolder22.3M5.6%Schedule 13G30 Jun 2026
Baillie Gifford & CoHolder18.2M4.51%*Form 13F30 Jun 2026
State StreetInstitution15.7M3.89%*Form 13F30 Jun 2026
Geode Capital ManagementInstitution9.7M2.40%*Form 13F30 Jun 2026
Morgan StanleyInstitution9.5M2.36%*Form 13F30 Jun 2026
Theleme Partners LLPInstitution8.1M1.99%*Form 13F30 Jun 2026
Two Sigma Investments, LPInstitution7.2M1.78%*Form 13F30 Jun 2026
Noubar B. Afeyan, Ph.D. · ChairmanInsider7.1M1.8%Proxy statement9 Mar 2026
UBSInstitution6.0M1.48%*Form 13F30 Jun 2026
InvescoInstitution5.8M1.43%*Form 13F30 Jun 2026
T. Rowe PriceInstitution5.6M1.38%*Form 13F30 Jun 2026
Stephen Hoge, M.D. · PresidentInsider5.2M1.3%Proxy statement9 Mar 2026
Charles SchwabInstitution4.8M1.20%*Form 13F30 Jun 2026

Insider transactions latest 25

InsiderDateTransactionSharesPriceValue
Hoge Stephen · President15 Oct 2026Option exercise+76.5K$12.21$933.5K
Hoge Stephen · President15 Oct 2026Open-market sale (10b5-1 plan)−39.1K$220.72$8.64M
Hoge Stephen · President14 Oct 2026Option exercise+76.5K$12.21$933.5K
Hoge Stephen · President14 Oct 2026Open-market sale (10b5-1 plan)−38.8K$213.47$8.28M
Hoge Stephen · President14 Oct 2026Open-market sale (10b5-1 plan)−450$214.15$96.37K
Mock James M · Chief Financial Officer5 Oct 2026Option exercise+1.5K——
Mock James M · Chief Financial Officer5 Oct 2026Shares withheld for tax−704$190.01$133.8K
Hoge Stephen · President15 Sep 2026Open-market sale (10b5-1 plan)−40.3K$146.07$5.88M
Hoge Stephen · President15 Sep 2026Option exercise+76.5K$12.21$933.5K
Hoge Stephen · President14 Sep 2026Open-market sale (10b5-1 plan)−40.3K$144.13$5.81M
Hoge Stephen · President14 Sep 2026Option exercise+76.5K$12.21$933.5K
Mock James M · Chief Financial Officer10 Sep 2026Option exercise+19.8K$30.96$614.1K
Mock James M · Chief Financial Officer10 Sep 2026Open-market sale (10b5-1 plan)−15.0K$134.49$2.02M
Mock James M · Chief Financial Officer10 Sep 2026Open-market sale (10b5-1 plan)−19.8K$134.49$2.67M
Mock James M · Chief Financial Officer4 Sep 2026Option exercise+11.8K——
Mock James M · Chief Financial Officer4 Sep 2026Shares withheld for tax−5.7K$148.87$849.2K
Klinger Shannon Thyme · Chief Legal Officer4 Sep 2026Shares withheld for tax−5.7K$148.87$849.2K
Klinger Shannon Thyme · Chief Legal Officer4 Sep 2026Option exercise+11.8K——
Klinger Shannon Thyme · Chief Legal Officer1 Sep 2026Option exercise+2.2K——
Klinger Shannon Thyme · Chief Legal Officer1 Sep 2026Shares withheld for tax−1.0K$140.34$147.1K
Klinger Shannon Thyme · Chief Legal Officer1 Sep 2026Option exercise+3.5K$30.96$107.5K
Klinger Shannon Thyme · Chief Legal Officer1 Sep 2026Open-market sale (10b5-1 plan)−3.5K$139.95$485.8K
Mock James M · Chief Financial Officer1 Sep 2026Option exercise+2.5K——
Mock James M · Chief Financial Officer1 Sep 2026Shares withheld for tax−1.2K$140.34$168.0K
Hoge Stephen · President1 Sep 2026Option exercise+9.3K——

Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.

MRNA in the terminal

Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.